FDA Gives Marijuana Testing Companies A Boost With New Exemption

FDA Gives Marijuana Testing Companies A Boost With New Exemption

The Food and Drug Administration (FDA) recently announced a policy change that will expedite the marketing of marijuana testing devices if they’re used for certain purposes. Many companies that manufacture medical devices are subject to FDA’s premarket notification requirements, which generally involve providing assurances that the products are safe and effective. But under the new guidelines, some cannabinoid testing instruments are exempt from that requirement, meaning they can get to market faster. However, a device does not qualify for the new exemption if it is “intended for any use other than employment or insurance testing or is intended for Federal drug testing programs,” according to a notice published in the Federal Register last week. FDA carved out more than 200 exemptions for a wide range of medical devices in the new filing. It took the action to comply with a 2016 law that instructs the agency to identify instruments that no longer require premarket notification and report them in the government publication. “FDA’s action decreases regulatory burden on the medical device industry and eliminates private costs and expenditures required to comply with certain Federal regulations,” the notice states. In order for the cannabis testing systems to be eligible for the…

Excerpt only …
READ MORE BELOW
Source : MJ moment
Link to original : FDA Gives Marijuana Testing Companies A Boost With New Exemption
reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.